Quantcast

Latest Human cytomegalovirus Stories

2014-09-08 16:25:41

Clinical testing volume and positivity rate both grew after the first case of the infectious disease spread to Western Hemisphere this year MADISON, N.J., Sept. 8, 2014 /PRNewswire/ -- A growing number of patients in the United States are being tested - and testing positive - for the mosquito-borne chikungunya virus, according to a study presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C. The study, by scientists from Quest Diagnostics...

2014-06-18 16:26:41

GERMANTOWN, Maryland, and HILDEN, Germany, June 18, 2014 /PRNewswire/ -- - Assay offers faster quantification of CMV DNA levels in patient samples - Up to 60% of all transplant patients are repeatedly tested for CMV viral load to help avoid potentially life-threatening conditions caused by this virus - PMA approval of artus(R) CMV RGQ MDx Kit adds further value to the QIAsymphony modular family of automated instruments as the...

2014-06-02 23:10:38

polyDNA’s May 2014 survey revealed that 14% of elderly respondents wanted to know if a common virus could cause inflammatory bowel disease. polyDNA reviews the literature and recommends taking Gene-Eden-VIR or Novirin. Rochester, NY (PRWEB) June 02, 2014 polyDNA’s latest survey discovered that some older participants wanted to know if a common virus could cause inflammatory bowel disease. The answer is “yes.” The cytomegalovirus (CMV) can cause inflammation of the colon. This is a...

2014-05-11 23:01:29

polyDNA’s April 2014 survey found that 24% of respondents wanted to know if a common virus can cause brain cancer. polyDNA reviews the literature on this topic and recommends Gene-Eden-VIR and Novirin against CMV, which is linked to some forms of brain cancer. Rochester, NY (PRWEB) May 11, 2014 In polyDNA’s April 2014 survey, 24% of respondents wanted to know if a virus can cause brain cancer. The answer is yes. Research shows that the human cytomegalovirus (CMV) is found “in brain...

2014-05-08 12:29:33

WUPPERTAL, Germany and WHITEHOUSE STATION, New Jersey, May 8, 2014 /PRNewswire/ -- AiCuris and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the publication of results from a Phase 2 clinical trial evaluating the safety and efficacy of letermovir, an investigational, oral antiviral agent for the prevention of human cytomegalovirus (CMV) infection in patients receiving bone marrow transplant. The results published in the latest issue of...

2014-04-11 12:05:26

Targeting cytomegalovirus may help restore health A virus that is present in most people in a latent state may induce or exacerbate anemia in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings point to a new therapeutic target for affected individuals. Chronic kidney disease (CKD) patients and kidney transplant recipients often develop anemia, or low levels of red blood cells. This...

2013-09-18 13:28:52

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus. The first-of-its-kind approach to preventing human CMV infection, developed by a team of scientists at UC Davis and the University of Alabama, Birmingham, induced broader...

2013-09-17 23:01:05

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus. Sacramento, PA (PRWEB) September 17, 2013 An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients,...

2013-08-01 23:26:03

According to a study published in the journal, Immunity and Aging on July 23, 2013, the concept of accelerating decline in the immune system caused by persistent infections has been suggested in many studies.(1) polyDNA recommends Gene-Eden-VIR to boost the immune system against latent viruses. Rochester, NY (PRWEB) August 01, 2013 Aging and latent viruses join forces in a vicious cycle. Aging decreases the efficiency of the immune system. As a result, the concentration of latent viruses...

2013-07-25 23:21:44

“Approximately one in five children with congenital CMV infection will develop permanent problems, such as hearing loss or developmental disabilities" according to an article published on July 12, 2013 in The Standard Examiner (1). polyDNA recommends cleansing the future parents’ bodies from viruses which may harm the baby. Rochester, NY (PRWEB) July 25, 2013 Women worried about having a healthy baby should ask their home states to copy the health initiative recently adopted by...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related